Jade Biosciences (JBIO) EPS (Diluted) (2021 - 2026)

Jade Biosciences (JBIO) EPS (Diluted) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.15
4 NuCana 279.75 Bn 279.75 Bn - -368,323.02
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.75
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.33
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 Jade Biosciences 16.25 Mn 16.25 Mn - -0.70

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.70
Dec 31, 2025 -1.12
Sep 30, 2025 -1.43
Jun 30, 2025 -2.46
Mar 31, 2025 -46.09
Dec 31, 2024 -57.53
Sep 30, 2024 -18.88
Jun 30, 2024 -32.71
Mar 31, 2024 -148.69
Dec 31, 2023 -29.49
Sep 30, 2023 -49.53
Jun 30, 2023 -69.89
Mar 31, 2023 -85.11
Dec 31, 2022 -22.57
Sep 30, 2022 -69.13
Jun 30, 2022 -62.87
Mar 31, 2022 -15.64
Dec 31, 2021 -23.41
Sep 30, 2021 -9.06